Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Incept BioSystems
AddedFeb 17, 2024
UpdatedJun 28, 2026
Incept BioSystems

Incept BioSystems

Series A

Enhancing IVF outcomes nationwide with innovative infertility treatments.

HQ
Ann Arbor, MI, US
Founded
2005
Overview
Compare
Fundraising
Employees

Incept BioSystems is dedicated to enhancing IVF outcomes nationwide with innovative infertility treatments. The company develops advanced systems aimed at improving the efficacy of the in-vitro fertilization process, catering to individuals and couples facing infertility challenges across the United States.

Incept BioSystems has made significant strides in the field of reproductive medicine, contributing to higher success rates in IVF treatments. Their pioneering technologies have positively impacted many lives, positioning them as a key player in the infertility treatment market.

Incept BioSystems - Similar Companies

Bioincept logo

Bioincept

bioincept.com

INVO Fertility logo

INVO Fertility

invobioscience.com

Conceivable Life Sciences logo

Conceivable Life Sciences

conceivable.life

Granata Bio logo

Granata Bio

granata.bio

US Fertility logo

US Fertility

usfertility.com

Microgenesis logo

Microgenesis

microgenesis.net

ReproHealth Technologies logo

ReproHealth Technologies

JumpStart Fertility logo

JumpStart Fertility

Inception Sciences logo

Inception Sciences

Darwin Life logo

Darwin Life

Mariposa Biotechnology logo

Mariposa Biotechnology

MedAnswers logo

MedAnswers

Overture Life logo

Overture Life

overture.life

Alife logo

Alife

alifehealth.com

Reproductive Solutions logo

Reproductive Solutions

Incept BioSystems - Quick Facts

Who are Incept BioSystems' competitors?

Companies similar to Incept BioSystems include Bioincept, INVO Fertility, Conceivable Life Sciences and Granata Bio.

When was Incept BioSystems founded?

Incept BioSystems was founded in 2005.

Where is Incept BioSystems' headquarters located?

Incept BioSystems' headquarters is located in Ann Arbor, MI, US.

When was Incept BioSystems' last funding round?

Incept BioSystems' most recent funding round was for $3.3M (USD) in April 2007.

How much has Incept BioSystems raised to-date?

As of Apr 26, 2007, Incept BioSystems has raised a total of $3.3M (USD).

How many employees does Incept BioSystems have?

Incept BioSystems has 3 employees as of Feb 10, 2024.

Incept BioSystems - Classification

Ownership
  • Private
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Software
Customer
  • Consumers
Main Product
  • Infertility Treatments
Tags
  • Healthtech
NAICS
  • 620000Health Care and Social Assistance
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
Show 1 more industry code
NAICS
  • 623000Nursing and Residential Care Facilities